FXR (NR1H4) modulating compounds
US12358903B2 · kind B2 · utility
0Cited by
28References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2022 |
| Grant date | Jul 15, 2025 |
| Priority date | — |
| Expiry date | May 18, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to compounds which bind to the NR1H4 receptor (FXR) and act as agonists of FXR. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and to a process for the synthesis of said compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.